Molecularly-targeted Strategy and NF-κB in lymphoid malignancies.

Journal of clinical and experimental hematopathology : JCEH

Volumn 53, Issue 3, 2013, Pages 185-195

  Horie, Ryouichi ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ANIMAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; LYMPHATIC LEUKEMIA; LYMPHOMA; METABOLISM; MOLECULARLY TARGETED THERAPY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; LEUKEMIA, LYMPHOID; LYMPHOMA; MOLECULAR TARGETED THERAPY; NF-KAPPA B; SIGNAL TRANSDUCTION;

EID: 84905636969     PISSN: None     EISSN: 18809952     Source Type: Journal    
DOI: 10.3960/jslrt.53.185     Document Type: Review

References (0)